JB Chemicals acquires brand 'Azmarda' from Novartis

13 Apr 2022 Evaluate

JB Chemicals & Pharmaceuticals has successfully completed the acquisition of the brand 'Azmarda' from Novartis AG, Switzerland. Azmarda indicated for heart failure patients with reduced ejection fraction (HfrEF).

JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).

JB Chem & Pharma Share Price

1865.70 7.60 (0.41%)
24-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1817.60
Dr. Reddys Lab 1351.25
Cipla 1475.90
Lupin 2168.30
Zydus Lifesciences 964.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.